220. Rapidly progressive glomerulonephritis Clinical trials / Disease details

Clinical trials : 2 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathway : 1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02647255 (ClinicalTrials.gov)	March 2016	21/12/2015	Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy	Randomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)	Glomerulonephritis, IGA;Kidney Diseases;Acute Renal Insufficiency;Rapidly Progressive Glomerulonephritis	Procedure: Plasma Exchange (PE);Drug: Methylprednisolone pulse	Peking University First Hospital	NULL	Terminated	14 Years	65 Years	All	10	Phase 2/Phase 3	China
2	NCT00354198 (ClinicalTrials.gov)	August 2006	18/7/2006	Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis	Clinical Efficacy of Combined Pentoxifylline and Conventional Immunosuppressive Regimens on Patients With Rapidly Progressive Glomerulonephritis	Glomerulonephritis	Drug: pentoxifylline;Drug: corticosteroids	National Taiwan University Hospital	National Science Council, Taiwan	Terminated	20 Years	80 Years	Both	7	Phase 3	Taiwan